250 related articles for article (PubMed ID: 23945289)
1. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.
Li D; Ilnytskyy Y; Kovalchuk A; Khachigian LM; Bronson RT; Wang B; Kovalchuk O
Oncotarget; 2013 Sep; 4(9):1373-87. PubMed ID: 23945289
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
3. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A
J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-20b (miR-20b) Promotes the Proliferation, Migration, Invasion, and Tumorigenicity in Esophageal Cancer Cells via the Regulation of Phosphatase and Tensin Homologue Expression.
Wang B; Yang J; Xiao B
PLoS One; 2016; 11(10):e0164105. PubMed ID: 27701465
[TBL] [Abstract][Full Text] [Related]
5. A novel regulatory loop miR-101/ANXA2/EGR1 mediates malignant characteristics of liver cancer stem cells.
Ma S; Cheng J; Wang H; Ding N; Zhou F; Ji R; Zhu L; Zhu C; Pan Y
Carcinogenesis; 2021 Feb; 42(1):93-104. PubMed ID: 32531042
[TBL] [Abstract][Full Text] [Related]
6. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
Park SL; Cho TM; Won SY; Song JH; Noh DH; Kim WJ; Moon SK
Oncol Rep; 2015 Sep; 34(3):1605-12. PubMed ID: 26166554
[TBL] [Abstract][Full Text] [Related]
8. hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of
Drobna M; Szarzyńska B; Jaksik R; Sędek Ł; Kuchmiy A; Taghon T; Van Vlierberghe P; Szczepański T; Witt M; Dawidowska M
Cells; 2020 May; 9(5):. PubMed ID: 32380791
[TBL] [Abstract][Full Text] [Related]
9. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
[TBL] [Abstract][Full Text] [Related]
10. Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway.
Wenzel K; Daskalow K; Herse F; Seitz S; Zacharias U; Schenk JA; Schulz H; Hubner N; Micheel B; Schlag PM; Osterziel KJ; Ozcelik C; Scherneck S; Jandrig B
Biol Chem; 2007 May; 388(5):489-95. PubMed ID: 17516844
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.
Ao X; Nie P; Wu B; Xu W; Zhang T; Wang S; Chang H; Zou Z
Cell Death Dis; 2016 Nov; 7(11):e2463. PubMed ID: 27831559
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
13. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2.
Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382
[TBL] [Abstract][Full Text] [Related]
14. miR-20b and miR-125a promote tumorigenesis in radioresistant esophageal carcinoma cells.
Chen D; Su H; Li Y; Wu X; Li Y; Wei C; Shi D; Gao Y; Zhou Q; Wang Q; Jin X; Xie C
Aging (Albany NY); 2021 Mar; 13(7):9566-9581. PubMed ID: 33714953
[TBL] [Abstract][Full Text] [Related]
15. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
16. EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer.
Kim J; Kang HS; Lee YJ; Lee HJ; Yun J; Shin JH; Lee CW; Kwon BM; Hong SH
Cancer Lett; 2014 Jul; 349(1):35-44. PubMed ID: 24704156
[TBL] [Abstract][Full Text] [Related]
17. FOCAD/miR-491-5p, downregulated by EGR1, function as tumor suppressor by inhibiting the proliferation and migration of gastric cancer cells.
Sun R; Liu Z; Lv Y; Yang Y; Yang Y; Xiang Y; Jiang Q; Zhao C; Lv M; Zhang J; Zhang J; Ding C; Zhou D
Prog Biophys Mol Biol; 2022 Dec; 176():25-37. PubMed ID: 35788362
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Monoamine Oxidase B Gene Expression: Key Roles for Transcription Factors Sp1, Egr1 and CREB, and microRNAs miR-300 and miR-1224.
Arige V; Agarwal A; Khan AA; Kalyani A; Natarajan B; Gupta V; Reddy SS; Barthwal MK; Mahapatra NR
J Mol Biol; 2019 Mar; 431(6):1127-1147. PubMed ID: 30738894
[TBL] [Abstract][Full Text] [Related]
19. EGR1 interacts with DNMT3L to inhibit the transcription of miR-195 and plays an anti-apoptotic role in the development of gastric cancer.
Yang Y; Wu F; Zhang J; Sun R; Li F; Li Y; Chang S; Wang L; Wang X; Liu L; Huang C
J Cell Mol Med; 2019 Nov; 23(11):7372-7381. PubMed ID: 31515938
[TBL] [Abstract][Full Text] [Related]
20. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]